AtriCure (NSDQ:ATRC) boosted its 1st quarter sales above Wall Street’s forecast, posting nearly 28% growth, and raised its outlook on revenues for the rest of the year.
2014
Covidien beats The Street by 1¢ in Q2
Listen to Edwards Lifesciences’ Q1 2014 earnings call
Edwards Lifesciences’ Sapien sales grow 11.5% in Q1
Medtech giant Edwards Lifesciences (NYSE:EW) posted Street-beating figures for its 1st quarter, driven largely by growth in its transcatheter heart valves.
C.R. Bard blows away sales and earnings expectations in Q1
Zimmer beats The Street, alters 2014 forecast on Biomet buy
Vascular Solutions lowers 2014 forecast on higher legal fees
Vascular Solutions (NSDQ:VASC) wasn’t making friends on Wall Street this week after the company missed expectations for Q1 and lowered its forecast for the rest of the year.
Listen to Stryker’s Q1 2014 earnings call
Recall charges continue to suck up Stryker’s profits
Intuitive Surgical sinks following rough Q1 report
Intuitive Surgical (NSDQ:ISRG) dropped more than 11% today as Wall Street reacted to the surgical systems maker’s disappointing 1st-quarter earnings.
Sales, earnings plunge for Intuitive Surgical during dreary Q1
Intuitive Surgical (NSDQ:ISRG) said sales dropped nearly 24% during the first 3 months of 2014, missing analysts’ estimates and sending shares down 4% in after-hours trading.